---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-26-003161"
form_type: "8-K"
ticker: "VBIO"
cik: "0001787740"
company_name: "Valion Bio, Inc."
filed_at: "2026-04-23T23:59:59+00:00"
generated_at: "2026-05-15T04:36:03.755627+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Tivic Health rebrands as Valion Bio; ticker to VBIO; targets BARDA SNS procurement for Entolimod

## Summary
- Corporate name changes to Valion Bio, Inc.; Nasdaq ticker to change from TIVC to VBIO effective April 28, 2026.
- Lead asset Entolimod (TLR5 agonist) for Acute Radiation Syndrome has FDA Fast Track, Orphan Drug, and Animal Rule designations.
- Engaged with BARDA, DTRA, NIAID for Strategic National Stockpile procurement; potential nine-figure non-dilutive revenue event.
- Parallel oncology indication: chemotherapy-induced neutropenia; targeting Phase IIb readiness; market over $22B.
- Velocity Bioworks CDMO subsidiary (acquired ~$16.3M) completed 200-fold scale-up; offers independent third-party revenue stream.

## SEC filing metadata
- accession: 0001683168-26-003161
- form_type: 8-K
- ticker: VBIO
- cik: 0001787740
- company_name: Valion Bio, Inc.
- filed_at: 2026-04-23T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787740/000168316826003161/0001683168-26-003161-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787740/000168316826003161/tivic_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-26-003161
- JSON: https://secwatch.observer/filing/0001683168-26-003161.json
- Plain text: https://secwatch.observer/filing/0001683168-26-003161.txt

## Source-grounded claims
- claim_id: 24d34c8156989dbfff8513a07d620ffc4fdc0392
  claim: Valion Bio, Inc.: Changed corporate name from Tivic Health Systems, Inc. to Valion Bio, Inc (effective 2026-04-28).
  evidence_excerpt: On April 22, 2026, Tivic Health Systems, Inc. (the “Company”) filed a certificate of amendment (“Certificate of Amendment”) to its amended and restated certificate of incorporation filed with the Delaware Secretary of State to change its corporate name to Valion Bio, Inc. (the “Name Change”), effective as of April 28, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1787740/000168316826003161/0001683168-26-003161-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.